These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38581025)

  • 21. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.
    Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D
    J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
    Zuo X; Cai J; Chen Z; Li Y; Zhang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperglycemia induces miR-26-5p down-regulation to overexpress PFKFB3 and accelerate epithelial-mesenchymal transition in gastric cancer.
    He X; Cheng X; Ding J; Xiong M; Chen B; Cao G
    Bioengineered; 2022 Feb; 13(2):2902-2917. PubMed ID: 35094634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.
    Ge Y; Li Q; Lin L; Jiang M; Shi L; Wang B; Yang L; Xu Z
    Cell Biochem Funct; 2020 Jan; 38(1):28-37. PubMed ID: 31710389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystatin 2 leads to a worse prognosis in patients with gastric cancer.
    Zhang WP; Wang Y; Tan D; Xing CG
    J Biol Regul Homeost Agents; 2020; 34(6):2059-2067. PubMed ID: 33302616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
    Tian S; Zhan N; Li R; Dong W
    Med Sci Monit; 2019 Apr; 25():3115-3126. PubMed ID: 31028714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pan-cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer.
    Ju Y; Wang Z; Wang Q; Jin S; Sun P; Wei Y; Zhu G; Wang K
    J Cell Mol Med; 2024 Aug; 28(15):e18579. PubMed ID: 39086142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.
    Wu Q; Xiang S; Ma J; Hui P; Wang T; Meng W; Shi M; Wang Y
    Mol Oncol; 2018 Jun; 12(6):799-813. PubMed ID: 29489064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagen type IV alpha 1 (COL4A1) silence hampers the invasion, migration and epithelial-mesenchymal transition (EMT) of gastric cancer cells through blocking Hedgehog signaling pathway.
    Cui X; Shan T; Qiao L
    Bioengineered; 2022 Apr; 13(4):8972-8981. PubMed ID: 35297303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
    Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
    Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel role and function of LINC01235 in metastasis of gastric cancer cells by inducing epithelial-mesenchymal transition.
    Zhang C; Liang Y; Zhang CD; Pei JP; Wu KZ; Li YZ; Dai DQ
    Genomics; 2021 May; 113(3):1504-1513. PubMed ID: 33771634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
    Chen XB; Li W; Chu AX
    J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer.
    Fang W; Wan D; Yu Y; Zhang L
    Biomol Biomed; 2024 Jan; 24(1):101-124. PubMed ID: 37597212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer.
    Jiang M; Shi L; Yang C; Ge Y; Lin L; Fan H; He Y; Zhang D; Miao Y; Yang L
    Cell Death Dis; 2019 Jan; 10(1):32. PubMed ID: 30631050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive analysis of potential gastric cancer prognostic biomarker ITGBL1 associated with immune infiltration and epithelial-mesenchymal transition.
    Wang Z; Fu L; Zhang J; Ge Y; Guo C; Wang R; Deng M; Wang Q; Wang Z
    Biomed Eng Online; 2022 May; 21(1):30. PubMed ID: 35596183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis.
    Zhang JN; Wei F; Lei LH; Yang Y; Yang Y; Zhou WP
    Bioengineered; 2021 Dec; 12(2):11728-11739. PubMed ID: 34784846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.